Clinical Trials Browser

Neoplasms × Anastrozole × Breast × Clear all

Squamous Cell Carcinoma of Head and Neck, Breast Diseases, Breast Neoplasms, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Neoplasms, Neoplasms by Site, Hereditary Sensory and Autonomic Neuropathies, Ovarian Neoplasms, Endometrial Neoplasms

NCT05645536 2026-01-12

Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA Study

Phase 3 Enrolling by invitation

250 enrolled

Breast

Breast Neoplasms, Neoplasms

NCT04711252 2025-10-14

SERENA-4

Phase 3 Active not recruiting

1,370 enrolled

Breast

Breast Diseases, Breast Neoplasms, Neoplasm Metastasis, Neoplasms, Neoplasms by Site, Skin Diseases

NCT03099174 2025-06-24

This Study in Patients With Different Types of Cancer (Solid Tumours) Aims to Find a Safe Dose of Xentuzumab in Combination With Abemaciclib With or Without Hormonal Therapies. The Study Also Tests How Effective These Medicines Are in Patients With Lung and Breast Cancer

Phase 1 Completed

133 enrolled 26 charts

Breast

Breast Neoplasms, Neoplasms

NCT06341283 2024-05-10

A Retrospective Real-world Study of Abemaciclib in HR+ Breast Cancer

Not yet recruiting

200 enrolled

Breast

Breast Diseases, Breast Neoplasms, Neoplasms

NCT06154590 2023-12-04

NASBP-B-09

Not yet recruiting

100 enrolled

Breast

Breast Neoplasms, Neoplasms, Muscle Neoplasms, Chronic Pain

NCT01151215 2014-07-25

MINT

Phase 2 Terminated

482 enrolled 10 charts

Breast

Breast Neoplasms, Neoplasm Metastasis, Neoplasms

NCT00605267 2012-09-06

Arimidex/Tamoxifen Neo Adjuvant Study in Premenopausal Patients With Breast Cancer Under Anti Hormonal Treatment

Phase 3 Completed

197 enrolled 23 charts

Breast

Breast Neoplasms, Neoplasms

NCT00256698 2012-08-01

FACT

Phase 3 Completed

514 enrolled 13 charts

Breast

Breast Neoplasms, Neoplasms, Recurrence

NCT00357110 2010-12-21

@FAME

Phase 2 Completed

13 enrolled 7 charts

Breast

Breast Neoplasms, Neoplasms

Clinical Trials

PIKALO-1

Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA Study

SERENA-4

This Study in Patients With Different Types of Cancer (Solid Tumours) Aims to Find a Safe Dose of Xentuzumab in Combination With Abemaciclib With or Without Hormonal Therapies. The Study Also Tests How Effective These Medicines Are in Patients With Lung and Breast Cancer

A Retrospective Real-world Study of Abemaciclib in HR+ Breast Cancer

NASBP-B-09

MINT

Arimidex/Tamoxifen Neo Adjuvant Study in Premenopausal Patients With Breast Cancer Under Anti Hormonal Treatment

FACT

@FAME